全文获取类型
收费全文 | 309篇 |
免费 | 16篇 |
国内免费 | 57篇 |
出版年
2023年 | 4篇 |
2022年 | 16篇 |
2021年 | 18篇 |
2020年 | 7篇 |
2019年 | 8篇 |
2018年 | 7篇 |
2017年 | 6篇 |
2016年 | 10篇 |
2015年 | 16篇 |
2014年 | 19篇 |
2013年 | 28篇 |
2012年 | 34篇 |
2011年 | 42篇 |
2010年 | 15篇 |
2009年 | 11篇 |
2008年 | 16篇 |
2007年 | 12篇 |
2006年 | 14篇 |
2005年 | 13篇 |
2004年 | 18篇 |
2003年 | 6篇 |
2002年 | 13篇 |
2001年 | 6篇 |
2000年 | 4篇 |
1999年 | 9篇 |
1998年 | 6篇 |
1997年 | 9篇 |
1996年 | 1篇 |
1995年 | 4篇 |
1993年 | 1篇 |
1992年 | 3篇 |
1991年 | 1篇 |
1990年 | 2篇 |
1989年 | 2篇 |
1985年 | 1篇 |
排序方式: 共有382条查询结果,搜索用时 31 毫秒
381.
J Zhang A I Roberts C Liu G Ren G Xu L Zhang S Devadas Yufang Shi 《Cell death and differentiation》2013,20(12):1731-1741
Helper T cells are crucial for maintaining proper immune responses. Yet, they have an undefined relationship with one of the most potent immune stimulatory cytokines, granulocyte macrophage-colony-stimulating factor (GM-CSF). By depleting major cytokines during the differentiation of CD4+ T cells in vitro, we derived cells that were found to produce large amounts of GM-CSF, but little of the cytokines produced by other helper T subsets. By their secretion of GM-CSF, this novel subset of helper T cells (which we have termed ThGM cells) promoted the production of cytokines by other T-cell subtypes, including type 1 helper T cell (Th1), type 2 helper T cell (Th2), type 1 cytotoxic T cell (Tc1), type 2 cytotoxic T cell (Tc2), and naive T cells, as evidenced by the fact that antibody neutralization of GM-CSF abolished this effect. ThGM cells were found to be highly prone to activation-induced cell death (AICD). Inhibitors of TRAIL or granzymes could not block AICD in ThGM cells, whereas inhibition of FasL/Fas interaction partially rescued ThGM cells from AICD. Thus, ThGM cells are a novel subpopulation of T helper cells that produce abundant GM-CSF, exhibit exquisite susceptibility to apoptosis, and therefore play a pivotal role in the regulation of the early stages of immune responses. 相似文献
382.
Tania Velletri Yin Huang Yu Wang Qing Li Mingyuan Hu Ningxia Xie Qian Yang Xiaodong Chen Qing Chen Peishun Shou Yurun Gan Eleonora Candi Margherita Annicchiarico-Petruzzelli Massimiliano Agostini Huilin Yang Gerry Melino Yufang Shi Ying Wang 《Cell death and differentiation》2021,28(1):156
p53 plays a pivotal role in controlling the differentiation of mesenchymal stem cells (MSCs) by regulating genes involved in cell cycle and early steps of differentiation process. In the context of osteogenic differentiation of MSCs and bone homeostasis, the osteoprotegerin/receptor activator of NF-κB ligand/receptor activator of NF-κB (OPG/RANKL/RANK) axis is a critical signaling pathway. The absence or loss of function of p53 has been implicated in aberrant osteogenic differentiation of MSCs that results in higher bone formation versus erosion, leading to an unbalanced bone remodeling. Here, we show by microCT that mice with p53 deletion systemically or specifically in mesenchymal cells possess significantly higher bone density than their respective littermate controls. There is a negative correlation between p53 and OPG both in vivo by analysis of serum from p53+/+, p53+/−, and p53−/− mice and in vitro by p53 knockdown and ChIP assay in MSCs. Notably, high expression of Opg or its combination with low level of p53 are prominent features in clinical cancer lesion of osteosarcoma and prostate cancer respectively, which correlate with poor survival. Intra-bone marrow injection of prostate cancer cells, together with androgen can suppress p53 expression and enhance local Opg expression, leading to an enhancement of bone density. Our results support the notion that MSCs, as osteoblast progenitor cells and one major component of bone microenvironment, represent a cellular source of OPG, whose amount is regulated by the p53 status. It also highlights a key role for the p53-OPG axis in regulating the cancer associated bone remodeling.Subject terms: Cell biology, Pathogenesis 相似文献